Full-Time

Health IT Program Manager

Confirmed live in the last 24 hours

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Biotechnology
Healthcare

Compensation Overview

$131.3k - $191.1kAnnually

Senior

Remote in USA

This is a remote position that can be located anywhere in the US.

Category
Project Management
Business & Strategy
Required Skills
Visio
Word/Pages/Docs
PowerPoint/Keynote/Slides

You match the following iRhythm Technologies's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • At least 5 years of experience with EHRs (Epic, Cerner, or Athenahealth experience preferred)
  • Significant knowledge of, and experience with, EMR workflow development and best practices for user adoption and education within a health system setting
  • Experience working in the cardiology space is ideal, either in an operational or support role within the health system or vendor
  • Demonstrated strategic, analytical and problem-solving thinking
  • Significant experience with Microsoft Office (Visio, Word, PowerPoint) and associated tools for workflow documentation, user education, and project management
  • Excellent communication and presentation skills
  • Proven success working with health systems or providers in a strategic and consultative capacity, ideally including how to effectively leverage Health IT tools with customers and prospects
  • Strong understanding of the healthcare landscape and health economics is preferred
  • Experience in a clinical informatics role (either at a health system or vendor) is a bonus
  • Bachelor’s degree or relevant experience in the healthcare field
  • Ability to travel up to 50% of the time, as needed
Responsibilities
  • Support company priorities such as improving device return rates, increasing patient access and care pathway development, and partnering with our product team to drive a customer-centric roadmap
  • Deeply understand our customers’ workflows (in the EMR and in care settings) and develop best practices for implementation of our Zio service via available technology solutions
  • Assist sales and account management teams in explaining iRhythm’s EHR integration workflows, optimal EMR configuration opportunities, and recommendations to prospective customers
  • Establish relationships with high priority decision makers, physicians, and C-Suite in health information technology to facilitate access to Zio and influence further adoption
  • Align iRhythm digital capabilities with customer EHR capabilities to enhance the experience with Zio for clinicians, support staff, and administrators
  • Assist commercial organization in monitoring external technical and business environment for innovative needs, and in developing new resources for use with customers
  • Identify and develop key opportunities between iRhythm and relevant HIT vendors, influencers, policy makers, customers or other key stakeholders across the industry
  • Provide educational support to the broader iRhythm commercial teams regarding existing capabilities and emerging trends/implications in our digital technology solutions
  • Oversee and facilitate the development of processes and best practices to incorporate into our EHR integration implementations. Develop tracking tools and feedback mechanisms to ensure these are broadly adopted and are making the intended impact
  • Based on customer success data for health systems, identify opportunities for workflow or process improvement and coordinate effective follow up to drive those improvements
  • Develop KPIs that demonstrate the importance and impact of an effective adoption and readiness program for customers implementing an EHR integrated workflow. Own the ongoing improvement of these measures
  • Develop post-implementation workflow adoption tracking mechanisms and processes for re-engaging with customers as needed
Desired Qualifications
  • Experience in a clinical informatics role (either at a health system or vendor) is a bonus
  • Strong understanding of the healthcare landscape and health economics is preferred

iRhythm Technologies specializes in cardiac monitoring solutions, primarily through its product, the Zio Patch. This wearable device allows for up to 14 days of continuous heart rhythm tracking, enabling healthcare providers to detect irregular heart rhythms that may not be identified during shorter monitoring periods. The Zio Patch is particularly useful for patients who suspect heart rhythm issues, as it allows them to monitor their heart activity without frequent visits to healthcare facilities, which is especially important in the context of telehealth and COVID-19. Unlike many competitors, iRhythm not only provides the monitoring device but also offers data analysis services that interpret the collected data, giving healthcare providers actionable insights. The company's goal is to enhance patient outcomes and improve healthcare workflows by making cardiac monitoring more accessible and efficient.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

$102.8M

Headquarters

San Francisco, California

Founded

2006

Simplify Jobs

Simplify's Take

What believers are saying

  • Expansion into European markets increases revenue and brand presence.
  • AI integration enhances diagnostic accuracy and speed for cardiac arrhythmias.
  • Growing demand for remote monitoring boosts Zio Patch's market potential.

What critics are saying

  • Increased competition from new entrants may impact iRhythm's market share.
  • Securities fraud complaint could affect investor confidence and stock prices.
  • Regulatory scrutiny may lead to higher compliance costs and operational delays.

What makes iRhythm Technologies unique

  • Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
  • iRhythm's partnership with BioIntelliSense enhances multiparameter sensor capabilities.
  • Zio Patch is the smallest and least conspicuous cardiac arrhythmia diagnostic device.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Yahoo Finance
Jan 13th, 2025
Irhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights And Business Update At The 43Rd Annual J.P. Morgan Healthcare Conference

iRhythmSAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference.Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accountsLaunched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health systems across the U.S. beginning in 2025Initiated Zio monitor shipments for home enrollment patients during the fourth quarter 2024Five studies presented at the American Heart Association highlight Zio Monitor’s high patient satisfaction, engagement and compliance with the patient MyZio app and digital tools, health economic impact of early arrhythmia detection in type 2 diabetes and respiratory disease, and AI insights on sleep and activity patterns 1Expect revenue for the full year 2025 of approximately $675 million to $685 million“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S

MarketBeat
Nov 26th, 2024
Dynamic Technology Lab Private Ltd Invests $1.50 Million in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Dynamic Technology Lab Private Ltd invests $1.50 million in iRhythm Technologies, Inc. (NASDAQ:IRTC).

MPO Magazine
Oct 22nd, 2024
iRhythm Earns FDA Nod for Zio AT After Warning Letter

The letter accused iRhythm of violating Federal Food, Drug, and Cosmetic Act rules about labeling, medical device reporting, and quality systems.

Global Tech Times
Sep 20th, 2024
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm

Recently a securities fraud complaint was filed against iRhythm on behalf of investors who purchased shares of the company's stock between November 5, 2021 and May 30, 2023 (the "Class Period").

TipRanks
Sep 4th, 2024
iRhythm signs exclusive license agreement with BioIntelliSense

iRhythm Technologies announced that the company has signed an exclusive license agreement with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring, ACM.